Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Infinity enrolling patients in phase I trial of IPI-493 for hematologic malignancies

June 28, 2010

Phase I trial of XMT-1107 initiated in patients with refractory advanced solid tumors

June 28, 2010

Reduced melanoma cell growth observed in in vitro testing of GAP-107B8

June 28, 2010

First-in-human data presented on MLN-9708 in nonhematologic cancer

June 28, 2010

Novel RAF kinase inhibitors emerge from Takeda R&D

June 28, 2010

Nereus completes enrollment in phase II plinabulin trial in lung cancer

June 25, 2010

Mologen provides update on clinical status of MGN-1601 and MGN-1703

June 25, 2010

Temsirolimus is safe in children with neuroblastoma, high-grade glioma and rhabdomyosarcoma

June 25, 2010

New B-raf kinase inhibitors claimed by Korean scientists

June 25, 2010

Sorafenib exhibits antitumor activity in hematological malignancies in phase I trial

June 25, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 26, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026